tetano
Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep
. 2020 Nov 6;69(44):1635-1640.
doi: 10.15585/mmwr.mm6944e2.
Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020
Kate R Woodworth, Emily O'Malley Olsen, Varsha Neelam, Elizabeth L Lewis, Romeo R Galang, Titilope Oduyebo, Kathryn Aveni, Mahsa M Yazdy, Elizabeth Harvey, Nicole D Longcore, Jerusha Barton, Chris Fussman, Samantha Siebman, Mamie Lush, Paul H Patrick, Umme-Aiman Halai, Miguel Valencia-Prado, Lauren Orkis, Similoluwa Sowunmi, Levi Schlosser, Salma Khuwaja, Jennifer S Read, Aron J Hall, Dana Meaney-Delman, Sascha R Ellington, Suzanne M Gilboa, Van T Tong, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT)
Collaborators, Affiliations
Abstract
Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (<37 weeks), higher than the reported 10.2% among the general U.S. population in 2019 (4). Among 610 infants (21.3%) with reported SARS-CoV-2 test results, perinatal infection was infrequent (2.6%) and occurred primarily among infants whose mother had SARS-CoV-2 infection identified within 1 week of delivery. Because the majority of pregnant women with COVID-19 reported thus far experienced infection in the third trimester, ongoing surveillance is needed to assess effects of infections in early pregnancy, as well the longer-term outcomes of exposed infants. These findings can inform neonatal testing recommendations, clinical practice, and public health action and can be used by health care providers to counsel pregnant women on the risks of SARS-CoV-2 infection, including preterm births. Pregnant women and their household members should follow recommended infection prevention measures, including wearing a mask, social distancing, and frequent handwashing when going out or interacting with others or if there is a person within the household who has had exposure to COVID-19.[SUP]†[/SUP].
. 2020 Nov 6;69(44):1635-1640.
doi: 10.15585/mmwr.mm6944e2.
Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020
Kate R Woodworth, Emily O'Malley Olsen, Varsha Neelam, Elizabeth L Lewis, Romeo R Galang, Titilope Oduyebo, Kathryn Aveni, Mahsa M Yazdy, Elizabeth Harvey, Nicole D Longcore, Jerusha Barton, Chris Fussman, Samantha Siebman, Mamie Lush, Paul H Patrick, Umme-Aiman Halai, Miguel Valencia-Prado, Lauren Orkis, Similoluwa Sowunmi, Levi Schlosser, Salma Khuwaja, Jennifer S Read, Aron J Hall, Dana Meaney-Delman, Sascha R Ellington, Suzanne M Gilboa, Van T Tong, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT)
Collaborators, Affiliations
- PMID: 33151917
- DOI: 10.15585/mmwr.mm6944e2
Abstract
Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (<37 weeks), higher than the reported 10.2% among the general U.S. population in 2019 (4). Among 610 infants (21.3%) with reported SARS-CoV-2 test results, perinatal infection was infrequent (2.6%) and occurred primarily among infants whose mother had SARS-CoV-2 infection identified within 1 week of delivery. Because the majority of pregnant women with COVID-19 reported thus far experienced infection in the third trimester, ongoing surveillance is needed to assess effects of infections in early pregnancy, as well the longer-term outcomes of exposed infants. These findings can inform neonatal testing recommendations, clinical practice, and public health action and can be used by health care providers to counsel pregnant women on the risks of SARS-CoV-2 infection, including preterm births. Pregnant women and their household members should follow recommended infection prevention measures, including wearing a mask, social distancing, and frequent handwashing when going out or interacting with others or if there is a person within the household who has had exposure to COVID-19.[SUP]†[/SUP].